Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

SELL
$0.23 - $0.35 $2,285 - $3,477
-9,936 Reduced 69.03%
4,457 $1,000
Q1 2022

May 02, 2022

SELL
$0.28 - $0.68 $10,908 - $26,492
-38,959 Reduced 73.02%
14,393 $5,000
Q3 2021

Oct 28, 2021

SELL
$0.99 - $1.38 $13,563 - $18,906
-13,700 Reduced 20.43%
53,352 $65,000
Q2 2021

Aug 12, 2021

SELL
$1.14 - $1.87 $84,325 - $138,323
-73,970 Reduced 52.45%
67,052 $84,000
Q1 2021

Apr 26, 2021

BUY
$1.34 - $3.53 $185,837 - $489,558
138,685 Added 5934.32%
141,022 $251,000
Q4 2020

Feb 02, 2021

BUY
$0.87 - $1.26 $697 - $1,010
802 Added 52.25%
2,337 $2,000
Q3 2020

Oct 14, 2020

BUY
$0.93 - $1.35 $1,133 - $1,645
1,219 Added 385.76%
1,535 $1,000
Q2 2020

Jul 13, 2020

SELL
$0.97 - $1.7 $376 - $659
-388 Reduced 55.11%
316 $0
Q1 2020

Apr 29, 2020

SELL
$0.9 - $1.95 $2,660 - $5,764
-2,956 Reduced 80.77%
704 $0
Q4 2019

Feb 05, 2020

SELL
$1.0 - $1.49 $272 - $405
-272 Reduced 6.92%
3,660 $5,000
Q3 2019

Oct 15, 2019

BUY
$0.97 - $1.77 $2,294 - $4,186
2,365 Added 150.93%
3,932 $4,000
Q2 2019

Jul 26, 2019

BUY
$0.96 - $1.89 $1,133 - $2,232
1,181 Added 305.96%
1,567 $1,000
Q1 2019

Apr 18, 2019

SELL
$1.76 - $3.73 $55,464 - $117,547
-31,514 Reduced 98.79%
386 $0
Q4 2018

Jan 16, 2019

BUY
$2.01 - $4.21 $64,118 - $134,299
31,900 New
31,900 $117,000

About TYME TECHNOLOGIES, INC.


  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.